Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 16, 2018

In re Keryx Biopharmaceuticals, Inc.

Track this case

Case Number:

1:18-cv-01589

Court:

Delaware

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Colm F. Connolly

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 16, 2020

    Keryx Proxy Action Ignored 'Tailored Warning,' Judge Says

    A Delaware federal judge on Wednesday dismissed a shareholder's proposed class action alleging Keryx Biopharmaceuticals Inc. misled the public in the lead-up to a December 2018 shareholder vote on the company's acquisition by Akebia Therapeutics Inc.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login